title: Consensus of official position of IOF/ISCD FRAX initiatives in Asia-Pacific region.
abstract: The fracture risk assessment tool (FRAX(®)) has been developed for the identification of individuals with high risk of fracture in whom treatment to prevent fractures would be appropriate. FRAX models are not yet available for all countries or ethnicities, but surrogate models can be used within regions with similar fracture risk. The International Society for Clinical Densitometry (ISCD) and International Osteoporosis Foundation (IOF) are nonprofit multidisciplinary international professional organizations. Their visions are to advance the awareness, education, prevention, and treatment of osteoporosis. In November 2010, the IOF/ISCD FRAX initiative was held in Bucharest, bringing together international experts to review and create evidence-based official positions guiding clinicians for the practical use of FRAX. A consensus meeting of the Asia-Pacific (AP) Panel of the ISCD recently reviewed the most current Official Positions of the Joint Official Positions of ISCD and IOF on FRAX in view of the different population characteristics and health standards in the AP regions. The reviewed position statements included not only the key spectrum of positions but also unique concerns in AP regions.
authors.affiliation: Department of Family Medicine, National Cheng Kung University Hospital and College of Medicine, Tainan, Taiwan. Electronic address: paulo@mail.ncku.edu.tw.
authors.forename: Chih-Hsing
authors.initials: CH
authors.lastname: Wu
authors.affiliation: Academic Unit of Bone Metabolism, University of Sheffield, Sheffield, UK.
authors.forename: Eugene V
authors.initials: EV
authors.lastname: McCloskey
authors.affiliation: Osteoporosis Treatment Centre, Kuala Lumpur, Malaysia.
authors.forename: Joon Kiong
authors.initials: JK
authors.lastname: Lee
authors.affiliation: SCBR (Saitama Center for Bone Research), Kubojima Clinic, Saitama, Japan.
authors.forename: Akira
authors.initials: A
authors.lastname: Itabashi
authors.affiliation: Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia.
authors.forename: Richard
authors.initials: R
authors.lastname: Prince
authors.affiliation: Department of Radiology, Peking Union Medical College Hospital Beijing, Beijing, China.
authors.forename: Wei
authors.initials: W
authors.lastname: Yu
authors.affiliation: Department of Medicine, University of Santo Tomas Hospital, Manila, Philippines.
authors.forename: Julie
authors.initials: J
authors.lastname: Li-Yu
authors.affiliation: Division of Endocrinology, Department of Medicine, National University Health System, Singapore.
authors.forename: Siok Bee
authors.initials: SB
authors.lastname: Chionh
authors.affiliation: Obstetrician and Gynecologist in Beijing United Family Hospital, Beijing, China.
authors.forename: Yanling
authors.initials: Y
authors.lastname: Zhao
authors.affiliation: Seoul National University College of Medicine, Seoul, Korea.
authors.forename: Chan Soo
authors.initials: CS
authors.lastname: Shin
authors.affiliation: Jakarta Osteoporosis Center, Jakarta, Indonesia.
authors.forename: Tirtarahardja
authors.initials: T
authors.lastname: Gunawan
authors.affiliation: Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
authors.forename: Keh-Sung
authors.initials: KS
authors.lastname: Tsai
authors.affiliation: Osteoporosis Center, Taiwan Adventist Hospital, Taipei, Taiwan.
authors.forename: Poon-Ung
authors.initials: PU
authors.lastname: Chieng
authors.affiliation: Department of Nuclear Medicine and Radiology, Lin Shin Hospital, Taichung, Taiwan.
authors.forename: Sheng-Pin
authors.initials: SP
authors.lastname: Changlai
authors.affiliation: Department of Geriatrics and Gerontology, National Taiwan University Hospital, Taipei, Taiwan.
authors.forename: Ding-Cheng
authors.initials: DC
authors.lastname: Chan
authors.affiliation: Division of Endocrinology and Metabolism, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
authors.forename: Jung-Fu
authors.initials: JF
authors.lastname: Chen
authors.affiliation: Division of Rheumatology & Allergy, Vanderbilt University Medical Center, Nashville, TN, USA.
authors.forename: S Bobo
authors.initials: SB
authors.lastname: Tanner
authors.affiliation: Center of Bone Diseases, Department of Bone & Joint, Lausanne University Hospital, Lausanne, Switzerland.
authors.forename: Didier B
authors.initials: DB
authors.lastname: Hans
authors.affiliation: WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK.
authors.forename: John A
authors.initials: JA
authors.lastname: Kanis
authors.affiliation: Department of Family Medicine, National Cheng Kung University Hospital and College of Medicine, Tainan, Taiwan.
authors.forename: Yin-Fan
authors.initials: YF
authors.lastname: Chang
authors.affiliation: Secction of Family Medicine, Department of Internal Medicine, National Cheng Kung University Hospital Dou-Liou Branch, Douliou City, Taiwan.
authors.forename: Zih-Jie
authors.initials: ZJ
authors.lastname: Sun
authors.affiliation: Department of Orthopedics, National Taiwan University Hospital, Taipei, Taiwan.
authors.forename: Rong-Sen
authors.initials: RS
authors.lastname: Yang
mesh_terms: D006801:Humans; D015502:Absorptiometry, Photon; D000465:Algorithms; D001208:Asia; D044466:Asian People; D015519:Bone Density; D006305:Health Status Indicators; D044349:Oceania; D058866:Osteoporotic Fractures / Q000175:diagnosis / Q000453:epidemiology; D018570:Risk Assessment; D012307:Risk Factors
keywords: Bone mineral density; FRAX; clinical risk factor; fracture; osteoporosis